NextFerm Technologies is an Israel-based food tech company developing fermentation alternative proteins for supplements, food, and animal feeds. The company further engages in strain improvement as well as downstream and purification. Its flagship protein product ProteVin is a yeast-based non-GMO alternative protein produced using proprietary technology. The company supplies ProteVin to food and supplement manufacturers, most of which are in the plant-based sector. According to NextFerm, ProteVin has a neutral taste, contains a rich amino acid profile comparable to its animal counterparts, and has a high digestibility factor (PDCAST=1). It can also be used in a variety of alternative protein applications including plant-based meats and dairy as well as sports and nutrition products. As of June 2022, the company was in discussions with global food and dietary supplement producers for the integration of ProteVin into their alternative product lines.
In June 2022, the company completed its first commercial delivery in the US to SpaceMilk, a health and wellness brand. SpaceMilk had planned to launch a ProteVin-based product that summer.
The company was listed on the Tel Aviv Stock Exchange following its IPO in January 2020, where it raised USD 9.2 million at a valuation of USD 35.2 million.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.